• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无需冠状动脉造影(CAG),使用MI-MS ConvMixer + WSSE自动检测非ST段抬高型心肌梗死(NSTEMI)患者的闭塞主要冠状动脉

Automatic Detection of Occluded Main Coronary Arteries of NSTEMI Patients with MI-MS ConvMixer + WSSE Without CAG.

作者信息

Goktekin Mehmet Cagri, Gul Evrim, Çakmak Tolga, Demir Fatih, Kobat Mehmet Ali, Akbulut Yaman, Işık Ömer, Kadiroğlu Zehra, Demir Kürşat, Şengür Abdulkadir

机构信息

Emergency Medicine Department, School of Medicine, Firat University, Elazig 23119, Turkey.

Clinics of Cardiology, Balıkesir Atatürk City Hospital, Balıkesir 10050, Turkey.

出版信息

Diagnostics (Basel). 2025 Feb 2;15(3):347. doi: 10.3390/diagnostics15030347.

DOI:10.3390/diagnostics15030347
PMID:39941277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11817353/
Abstract

Heart attacks are the leading cause of death in the world. There are two important classes of heart attack: ST-segment Elevation Myocardial Infarction (STEMI) and Non-ST-segment Elevation Myocardial Infarction (NSTEMI) patient groups. While the STEMI group has a higher mortality rate in the short term, the NSTEMI group is considered more dangerous and insidious in the long term. Blocked coronary arteries can be predicted from ECG signals in STEMI patients but not in NSTEMI patients. Therefore, coronary angiography (CAG) is inevitable for these patients. However, in the elderly and some patients with chronic diseases, if there is a single blockage, the CAG procedure poses a risk, so medication may be preferred. In this study, a novel deep learning-based approach is used to automatically detect the occluded main coronary artery or arteries in NSTEMI patients. For this purpose, a new seven-class dataset was created with expert cardiologists. : A new Multi Input-Multi Scale (MI-MS) ConvMixer model was developed for automatic detection. The MI-MS ConvMixer model allows simultaneous training of 12-channel ECG data and highlights different regions of the data at different scales. In addition, the ConMixer structure provides high classification performance without increasing the complexity of the model. Moreover, to maximise the classifier performance, the WSSE algorithm was developed to adjust the classification prediction value according to the feature importance weights. This algorithm improves the SVM classifier performance. The features extracted from this model were classified with the WSSE algorithm, and an accuracy of 88.72% was achieved. : This study demonstrates the potential of the MI-MS ConvMixer model in advancing ECG signal classification for diagnosing coronary artery diseases, offering a promising tool for real-time, automated analysis in clinical settings. The findings highlight the model's ability to achieve high sensitivity, specificity, and precision, which could significantly improve.

摘要

心脏病发作是全球主要的死因。心脏病发作主要分为两类:ST段抬高型心肌梗死(STEMI)和非ST段抬高型心肌梗死(NSTEMI)患者群体。虽然STEMI组在短期内死亡率较高,但NSTEMI组从长期来看被认为更危险且隐匿。STEMI患者的心电图信号可以预测冠状动脉阻塞情况,但NSTEMI患者则不行。因此,这些患者不可避免地需要进行冠状动脉造影(CAG)。然而,对于老年人和一些患有慢性病的患者,如果存在单一阻塞,CAG操作存在风险,所以可能更倾向于药物治疗。在本研究中,采用了一种基于深度学习的新方法来自动检测NSTEMI患者中阻塞的主要冠状动脉。为此,与心脏病专家共同创建了一个新的七类数据集。开发了一种新的多输入多尺度(MI-MS)ConvMixer模型用于自动检测。MI-MS ConvMixer模型允许同时训练12通道心电图数据,并在不同尺度上突出显示数据的不同区域。此外,ConvMixer结构在不增加模型复杂度的情况下提供了较高的分类性能。而且,为了最大化分类器性能,开发了WSSE算法根据特征重要性权重调整分类预测值。该算法提高了支持向量机分类器的性能。用WSSE算法对从该模型提取的特征进行分类,准确率达到了88.72%。本研究证明了MI-MS ConvMixer模型在推进用于诊断冠状动脉疾病的心电图信号分类方面的潜力,为临床环境中的实时自动分析提供了一个有前景的工具。研究结果突出了该模型实现高灵敏度、特异性和精度的能力,这可能会显著提高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/8dfc9354cd6b/diagnostics-15-00347-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/a0ba16230bb1/diagnostics-15-00347-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/ad361f9bfcb6/diagnostics-15-00347-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/e77d6ecb93da/diagnostics-15-00347-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/c828a0b6dbb5/diagnostics-15-00347-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/490890a652a6/diagnostics-15-00347-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/4478e8f24387/diagnostics-15-00347-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/b68f859464d7/diagnostics-15-00347-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/8c3237cd6240/diagnostics-15-00347-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/fb210cef0ea7/diagnostics-15-00347-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/1e5ddc2dd0c6/diagnostics-15-00347-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/67d81c079e20/diagnostics-15-00347-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/5e412afa30ff/diagnostics-15-00347-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/8dfc9354cd6b/diagnostics-15-00347-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/a0ba16230bb1/diagnostics-15-00347-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/ad361f9bfcb6/diagnostics-15-00347-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/e77d6ecb93da/diagnostics-15-00347-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/c828a0b6dbb5/diagnostics-15-00347-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/490890a652a6/diagnostics-15-00347-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/4478e8f24387/diagnostics-15-00347-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/b68f859464d7/diagnostics-15-00347-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/8c3237cd6240/diagnostics-15-00347-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/fb210cef0ea7/diagnostics-15-00347-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/1e5ddc2dd0c6/diagnostics-15-00347-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/67d81c079e20/diagnostics-15-00347-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/5e412afa30ff/diagnostics-15-00347-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae89/11817353/8dfc9354cd6b/diagnostics-15-00347-g013.jpg

相似文献

1
Automatic Detection of Occluded Main Coronary Arteries of NSTEMI Patients with MI-MS ConvMixer + WSSE Without CAG.无需冠状动脉造影(CAG),使用MI-MS ConvMixer + WSSE自动检测非ST段抬高型心肌梗死(NSTEMI)患者的闭塞主要冠状动脉
Diagnostics (Basel). 2025 Feb 2;15(3):347. doi: 10.3390/diagnostics15030347.
2
Secondary electrocardiographic stratification of NSTEMI to identify an acutely occluded culprit artery.对 NSTEMI 进行二级心电图分层,以确定急性闭塞罪犯动脉。
Physiol Meas. 2023 Jul 17;44(7). doi: 10.1088/1361-6579/acddc8.
3
Patients with no significant lesions in coronary arteries and ST-segment elevation myocardial infarction have worse outcome than patients with non-ST-segment elevation myocardial infarction: analysis from PL-ACS Registry.无冠状动脉显著病变和 ST 段抬高型心肌梗死患者的预后比非 ST 段抬高型心肌梗死患者更差:来自 PL-ACS 注册研究的分析。
Kardiol Pol. 2010 Nov;68(11):1211-7.
4
Does heart rate variability correlate with long-term prognosis in myocardial infarction patients treated by early revascularization?早期血运重建治疗的心肌梗死患者的心率变异性与长期预后相关吗?
World J Cardiol. 2017 Jan 26;9(1):27-38. doi: 10.4330/wjc.v9.i1.27.
5
One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.直接经皮冠状动脉介入治疗无保护左主干冠状动脉闭塞所致 ST 段抬高型心肌梗死患者 1 年的转归。
Chin Med J (Engl). 2018 Jun 20;131(12):1412-1419. doi: 10.4103/0366-6999.233948.
6
Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.根据心电图模式(ST 段抬高型心肌梗死、非 ST 段抬高型心肌梗死和未分类型心肌梗死)和血运重建术对首次心肌梗死的长期预后进行评估。
Am J Cardiol. 2011 Oct 15;108(8):1061-7. doi: 10.1016/j.amjcard.2011.06.003. Epub 2011 Jul 24.
7
Total coronary occlusion in non ST elevation myocardial infarction: Time to change our practice?非 ST 段抬高型心肌梗死中的完全性冠状动脉闭塞:是时候改变我们的治疗策略了?
Int J Cardiol. 2021 Apr 15;329:1-8. doi: 10.1016/j.ijcard.2020.12.082. Epub 2021 Jan 4.
8
Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.东京都地区ST段抬高型和非ST段抬高型心肌梗死的当前特征与管理:来自东京CCU网络注册队列研究
Heart Vessels. 2016 Nov;31(11):1740-1751. doi: 10.1007/s00380-015-0791-9. Epub 2016 Jan 12.
9
ECG data analysis to determine ST-segment elevation myocardial infarction and infarction territory type: an integrative approach of artificial intelligence and clinical guidelines.用于确定ST段抬高型心肌梗死及梗死区域类型的心电图数据分析:人工智能与临床指南的综合方法
Front Physiol. 2024 Oct 7;15:1462847. doi: 10.3389/fphys.2024.1462847. eCollection 2024.
10
Contemporary NSTEMI management: the role of the hospitalist.当代非ST段抬高型心肌梗死的管理:住院医师的作用。
Hosp Pract (1995). 2020 Feb;48(1):1-11. doi: 10.1080/21548331.2020.1701329. Epub 2020 Feb 20.

本文引用的文献

1
Artificial intelligence-enhanced electrocardiography improves the detection of coronary artery disease.人工智能增强型心电图可改善冠状动脉疾病的检测。
Comput Struct Biotechnol J. 2024 Dec 27;27:278-286. doi: 10.1016/j.csbj.2024.12.032. eCollection 2025.
2
Pathophysiology, Diagnosis, and Management of Coronary Artery Disease in the Setting of Atrial Fibrillation.心房颤动背景下冠状动脉疾病的病理生理学、诊断与管理
J Am Heart Assoc. 2024 Dec 3;13(23):e037552. doi: 10.1161/JAHA.124.037552. Epub 2024 Nov 22.
3
Beyond troponins: Emerging diagnostic significance of novel markers in NSTEMI.
超越肌钙蛋白:新型标志物在非ST段抬高型心肌梗死中的新兴诊断意义
Glob Cardiol Sci Pract. 2024 Aug 1;2024(4):e202433. doi: 10.21542/gcsp.2024.33.
4
Pan-Immune-Inflammatory Value is Superior to Other Inflammatory Indicators in Predicting Inpatient Major Adverse Cardiovascular Events and Severe Coronary Artery Stenosis after Percutaneous Coronary Intervention in STEMI Patients.全免疫炎症值在预测ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后的住院主要不良心血管事件和严重冠状动脉狭窄方面优于其他炎症指标。
Rev Cardiovasc Med. 2024 Aug 20;25(8):294. doi: 10.31083/j.rcm2508294. eCollection 2024 Aug.
5
Clinical Updates in Coronary Artery Disease: A Comprehensive Review.冠状动脉疾病的临床进展:全面综述
J Clin Med. 2024 Aug 6;13(16):4600. doi: 10.3390/jcm13164600.
6
Integrated deep learning model for automatic detection and classification of stenosis in coronary angiography.用于冠状动脉造影中狭窄自动检测和分类的集成深度学习模型。
Comput Biol Chem. 2024 Oct;112:108184. doi: 10.1016/j.compbiolchem.2024.108184. Epub 2024 Aug 24.
7
Electroencephalogram-Based ConvMixer Architecture for Recognizing Attention Deficit Hyperactivity Disorder in Children.基于脑电图的ConvMixer架构用于识别儿童注意力缺陷多动障碍
Brain Sci. 2024 May 7;14(5):469. doi: 10.3390/brainsci14050469.
8
The Role of Pan-Immune-Inflammation Value in Determining the Severity of Coronary Artery Disease in NSTEMI Patients.全免疫炎症值在确定非ST段抬高型心肌梗死患者冠状动脉疾病严重程度中的作用
J Clin Med. 2024 Feb 25;13(5):1295. doi: 10.3390/jcm13051295.
9
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.急性 ST 段抬高型心肌梗死与非 ST 段抬高型心肌梗死患者的血管紧张素受体-脑啡肽酶抑制剂治疗。
J Am Coll Cardiol. 2024 Mar 5;83(9):904-914. doi: 10.1016/j.jacc.2024.01.002.
10
Recent advances in cardiovascular risk assessment: The added value of non-invasive anatomic imaging.心血管风险评估的最新进展:非侵入性解剖成像的附加价值。
J Cardiovasc Comput Tomogr. 2024 Mar-Apr;18(2):113-119. doi: 10.1016/j.jcct.2024.01.012. Epub 2024 Feb 6.